<DOC>
	<DOCNO>NCT00687388</DOCNO>
	<brief_summary>Non-steroidal Anti-inflammation Drugs effectively reduce low urinary tract symptom benign prostatic hyperplasia</brief_summary>
	<brief_title>The Clinical Efficacy Non-steroidal Anti-inflammation Drugs Patients With Benign Prostatic Hyperplasia</brief_title>
	<detailed_description />
	<mesh_term>Inflammation</mesh_term>
	<mesh_term>Hyperplasia</mesh_term>
	<mesh_term>Prostatic Hyperplasia</mesh_term>
	<mesh_term>Tamsulosin</mesh_term>
	<mesh_term>Doxazosin</mesh_term>
	<mesh_term>Terazosin</mesh_term>
	<mesh_term>Prazosin</mesh_term>
	<mesh_term>Alfuzosin</mesh_term>
	<mesh_term>Adrenergic alpha-Antagonists</mesh_term>
	<mesh_term>Anti-Inflammatory Agents , Non-Steroidal</mesh_term>
	<mesh_term>Celecoxib</mesh_term>
	<criteria>Who treatment BPH alpha1 blocker 3 month Who IPSS ( International Prostatic Symptom Score ) &gt; = 15 Who maximum flow rate ( Qmax ) &lt; 15 voided volume &gt; 150mL Who PPBC ( patient 's perception bladder condition ) &gt; = 3 ( The PPBC assess use six point order categorical scale ( 16 point ) . The high score mean high bother ) Who PSA level &lt; 4 ng/mL within 6 month ( But , patient reveal prostate cancer prostate biopsy include even PSA level 410 ng/mL ) Who underwent transrectal ultrasound prostate within 6 month Who understand study give inform consent Who regular intake 5alpha reductase inhibitor NSAID within 6 month screen Who peptic ulcer and/or asthma Who urologic malignancy prostate cancer bladder cancer Who urethral stricture , large bladder diverticuli , bladder neck contracture Who surgical treatment BPH Who histories bladder and/or urethra Who serum PSA level 10 ng/ml Who histories orthostatic hypotension Who serum creatinine level 2.0 mg/dl Who serum ALT and/or AST level 1.5 time normal upper limit Who heart failure Who histories bacterial prostatitis within 1 year Who histories active urinary tract infection within 1 month Who histories biopsy bladder prostate within 1 month Who unable void Who use pad incontinence Who hypersensitivities alpha blocker include quinazoline , NSAID , aspirin , sulfonamide Who histories unstable angina , myocardial infarction , cerebrovascular accident within 6 month Who neurogenic bladder due multiple sclerosis , Parkinson 's disease , Spinal injuries etc . Who think disturbance Who histories abuse alcohol and/or drug Who seem fit study decision investigator</criteria>
	<gender>Male</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>June 2013</verification_date>
	<keyword>Cyclooxygenase 2 Inhibitors</keyword>
	<keyword>Alpha Blockers</keyword>
	<keyword>Treatment Outcome</keyword>
</DOC>